Concerta 27mg (Methylphenidate Hydrochloride)

Concerta 27mg (Methylphenidate HCl) OROS Extended-Release Tablets is a prescription medication indicated for the comprehensive treatment of Attention Deficit Hyperactivity Disorder (ADHD). Formulated with advanced OROS® technology, this once-daily controlled stimulant releases a steady dose of methylphenidate throughout the day to help manage symptoms of inattention, hyperactivity, and impulsivity.
    • Active Ingredient: Methylphenidate Hydrochloride (27mg)
    • Delivery System: OROS® 12-Hour Extended Release
    • Pack Size: 30 Tablets
    • Manufacturer: Janssen

Always double-check the physical product label to confirm correct dosages and administration instructions before use.
Category:

Concerta 27mg (Methylphenidate Hydrochloride) 

is a prescription central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
The packaging image shows a box of 30 extended-release tablets manufactured by Janssen, featuring proprietary OROS® Technology designed for steady, all-day symptom control. Below is an SEO-optimized, highly structured overview of the product specifications, clinical indications, and essential safety guidelines based on medical standards. [1]

Product Specifications : Concerta 27mg (Methylphenidate Hydrochloride)
    • Brand Name: Concerta®
    • Active Ingredient: Methylphenidate Hydrochloride (27 mg per tablet)
    • Manufacturer: Janssen 
    • Formulation: Modified/prolonged-release oral tablet (capsule-shaped, grey, with “alza 27” printed on one side)
    • Delivery System: OROS® Advanced Osmotic Delivery Technology (engineered for a 12-hour continuous duration of effect)
    • Pack Size: 30 extended-release tablets
    • Regulatory Classification: Schedule 8 / Controlled Drug (requires specific medical authorization)
    • Storage Requirements: Store below 25°C in a tightly closed container. 


Key Clinical Benefits & Indications
    • Targeted ADHD Symptom Management: Indicated as an integral part of a total treatment program for ADHD in patients aged 6 to 65 years old who experience persistent hyperactive-impulsive or inattentive symptoms. [1, 2]
    • Comprehensive Care Approach: Designed to be used alongside psychological, educational, and social therapeutic measures. [1]
    • Once-Daily Convenience: The specialized OROS® mechanism slowly pushes out the active ingredient through a microscopic laser-drilled hole as it passes through the digestive tract. This provides smooth, stable symptom control from morning until night, eliminating the need for mid-day redosing. [1]


             Usage & Dosage Instructions: Buy Concerta 27mg in Australia
    • Administration: Must be taken once daily in the morning with or without food. [1]
    • Important Instructions: The tablet must be swallowed whole with a liquid. Do not crush, chew, or divide the tablet, as doing so will destroy the extended-release OROS® mechanism and release the full dose immediately, which can be dangerous. [1, 2]
    • Verification: Make sure to double-check the physical box label to confirm product names, dosages, and expiration dates match your official prescription.


Key Contraindications & Safety Warnings : Concerta 27mg (Methylphenidate Hydrochloride)
Before initiation, a full assessment by a qualified medical specialist is required. Concerta may not be suitable for everyone: [1]
    • Cardiovascular Risks: Central nervous system stimulants can increase heart rate and blood pressure. It is contraindicated in patients with severe pre-existing cardiovascular disorders, including advanced hypertension, heart failure, or severe arrhythmias. [1, 2]
    • Psychiatric Conditions: Contraindicated in individuals experiencing severe anxiety, tension, agitation, or poorly controlled bipolar disorder, as it may aggravate symptoms. [1, 2]
    • Glaucoma and Tics: Contraindicated for individuals with angle-closure glaucoma or a personal/family history of motor tics or Tourette’s syndrome. [1, 2]
    • Drug Interactions: Must not be taken concurrently with, or within 14 days of discontinuing, Monoamine Oxidase Inhibitors (MAOIs) due to the risk of a hypertensive crisis. [1, 2]


Medical Disclaimer: This product description is for informational and educational purposes only and is compiled from authoritative pharmaceutical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult with a licensed doctor or pharmacist regarding your specific healthcare needs and prescription medications.

Reviews

There are no reviews yet.

Be the first to review “Concerta 27mg (Methylphenidate Hydrochloride)”

Your email address will not be published. Required fields are marked *